<html>
<link rel="stylesheet" href="../datatable/css/demo_page.css" type="text/css" id=""/>
<link rel="stylesheet" href="../datatable/css/demo_table.css" type="text/css" id=""/>
<link rel="stylesheet" href="../style.css" type="text/css" id=""/>
<script type="text/javascript" src="http://code.jquery.com/jquery-1.11.0.min.js"></script>
<script type="text/javascript" src="../datatable/js/jquery.dataTables.js"></script>


<script type="text/javascript" id="js">
  $(document).ready(function() {
  // call the tablesorter plugin
      $("#NTAuNjgtMTc5MjU").dataTable({
        "bPaginate": false,
        "bLengthChange": false,
        "bInfo": false,
        "bStateSave": true,
        "bSort": false
      });
}); </script>

<body id="dt_example"><div id="container" style="width:80%"><h1>GLIMEPIRIDE 4MG/ROSIGLITAZONE MALEATE 4MG TAB (17925) &nbsp;&nbsp;  VA PRODUCT (50.68)</h1>
<div id="demo"><table id="NTAuNjgtMTc5MjU" class="display">
<thead>
<tr>
<th>Name</th>
<th>Value</th>
</tr>
</thead>
<tbody>
<tr>
<td>NAME</td>
<td>GLIMEPIRIDE 4MG/ROSIGLITAZONE MALEATE 4MG TAB</td>
</tr>
<tr>
<td>VA GENERIC NAME</td>
<td><a href="50.6-4205.html">GLIMEPIRIDE/ROSIGLITAZONE</a></td>
</tr>
<tr>
<td>DOSAGE FORM</td>
<td><a href="50.606-63.html">TAB</a></td>
</tr>
<tr>
<td>NATIONAL FORMULARY NAME</td>
<td>GLIMEPIRIDE/ROSIGLITAZONE TAB</td>
</tr>
<tr>
<td>VA PRINT NAME</td>
<td>GLIMEPIRIDE 4MG/ROSIGLITAZONE 4MG TAB</td>
</tr>
<tr>
<td>VA PRODUCT IDENTIFIER</td>
<td>G0272</td>
</tr>
<tr>
<td>TRANSMIT TO CMOP</td>
<td>YES</td>
</tr>
<tr>
<td>VA DISPENSE UNIT</td>
<td><a href="50.64-1.html">TAB</a></td>
</tr>
<tr>
<td>ACTIVE INGREDIENTS</td>
<td>
<ol>
<li>
<dt>ACTIVE INGREDIENTS:  &nbsp;&nbsp;<a href="50.416-3607.html">GLIMEPIRIDE</a></dt>
<dt>STRENGTH:  &nbsp;&nbsp;4</dt>
<dt>UNITS:  &nbsp;&nbsp;<a href="50.607-20.html">MG</a></dt>
</li>
<li>
<dt>ACTIVE INGREDIENTS:  &nbsp;&nbsp;<a href="50.416-3835.html">ROSIGLITAZONE MALEATE</a></dt>
<dt>STRENGTH:  &nbsp;&nbsp;4</dt>
<dt>UNITS:  &nbsp;&nbsp;<a href="50.607-20.html">MG</a></dt>
</li>
</ol>
</td>
</tr>
<tr>
<td>PRIMARY VA DRUG CLASS</td>
<td><a href="50.605-130.html">HS502</a></td>
</tr>
<tr>
<td>NATIONAL FORMULARY INDICATOR</td>
<td>NO</td>
</tr>
<tr>
<td>CS FEDERAL SCHEDULE</td>
<td>Unscheduled</td>
</tr>
<tr>
<td>SINGLE/MULTI SOURCE PRODUCT</td>
<td>Single source</td>
</tr>
<tr>
<td>OVERRIDE DF DOSE CHK EXCLUSION</td>
<td>NO</td>
</tr>
<tr>
<td>CREATE DEFAULT POSSIBLE DOSAGE</td>
<td>YES</td>
</tr>
<tr>
<td>MASTER ENTRY FOR VUID</td>
<td>YES</td>
</tr>
<tr>
<td>VUID</td>
<td>4025627</td>
</tr>
<tr>
<td>EFFECTIVE DATE/TIME</td>
<td>
<ol>
<li>
<dt>EFFECTIVE DATE/TIME:  &nbsp;&nbsp;2006-10-11 00:00:00</dt>
<dt>STATUS:  &nbsp;&nbsp;ACTIVE</dt>
</li>
</ol>
</td>
</tr>
<tr>
<td>FDA MED GUIDE</td>
<td>Glimepiride-Rosiglitazone_(Avandaryl)_(Nov_2011).pdf</td>
</tr>
<tr>
<td>SERVICE CODE</td>
<td>617925</td>
</tr>
</tbody>
</table>
</div>
</div>
</body></html>